Brief: Qlife Collaboration Agreement With Hipro Biotechnology Has Potential Value Of SEK 500 Mln
Dec 7 (Reuters) - Qlife Holding AB QLIFE.ST :
* QLIFE COLLABORATION AGREEMENT WITH HIPRO BIOTECHNOLOGY -
POTENTIAL VALUE OF 500 MSEK
* QLIFE HAS ON MONDAY 4(TH) OF DECEMBER ENTERED INTO A FINAL
COLLABORATION AGREEMENT WITH HIPRO BIOTECHNOLOGY
Source text for Eikon: ID:nWkr2xTF5n
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Qlife Holding AB
See all newsAdvisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million